Utrecht Health Seed Fund

Phlox Therapeutics is a biotechnology company focused on developing gene therapies aimed at alleviating and curing cardiomyopathies and other heart diseases. The company leverages innovative technologies, including RNA-based therapeutics, to provide long-lasting benefits for patients affected by genetic mutations. By offering advanced therapeutic solutions, Phlox Therapeutics seeks to address the underlying causes of genetic heart diseases, ultimately improving patient outcomes and quality of life.

Synerkine Pharma is engaged in the development of innovative fusion proteins aimed at treating inflammatory, neuropathic, and osteoarthritic pain. The company's focus lies in targeting common regulatory mechanisms associated with various forms of chronic pain. Its fusion proteins possess distinctive properties that help normalize pain and inhibit inflammation, thereby offering potential solutions for patients suffering from different pain types. Through its research and development efforts, Synerkine Pharma seeks to provide pharmaceutical products that effectively reduce pain, as demonstrated in multiple pre-clinical models.

Cordys Analytics specializes in AI-driven cardiac diagnostics. It develops an AI-based platform that interprets electrocardiograms (ECGs), enabling healthcare providers to detect heart illnesses more efficiently and affordably. This platform aims to improve cardiac care by offering timely, accurate diagnoses close to patients, reducing the burden on healthcare systems.

Moveshelf is a cloud-based SaaS platform designed to aid 3D character animators, motion capture technicians, and movement scientists in managing human motion data. The application provides a user-friendly web interface accessible via smartphones, tablets, and computers, enabling professionals to securely store, organize, analyze, and share 3D data. Compatible with all major motion capture systems and various 3D motion data file formats, Moveshelf allows for seamless collaboration and data exchange among teams. The platform supports integration with open-source APIs in Python, Node.js, and popular development environments such as Unity, Unreal, and MATLAB. It offers a secure environment for movement scientists and healthcare professionals to generate interactive reports and datasets, facilitating effective communication and data analysis. Founded by experts in technology and motion tracking, Moveshelf aims to enhance the usability and accessibility of 3D human motion data, empowering professionals to achieve greater results in their work.

TargED Biopharmaceuticals is a biotechnology company focused on developing innovative biological drugs aimed at enhancing the treatment of thrombosis. The company utilizes small antibodies, known as VhH, to deliver enzymes directly to the sites of thrombus, facilitating targeted thrombolysis. This approach allows for effective treatment regardless of the blood clot's composition, thereby enabling healthcare professionals to accelerate patient care and improve outcomes for those affected by thrombosis.

Moveshelf is a cloud-based SaaS platform designed to aid 3D character animators, motion capture technicians, and movement scientists in managing human motion data. The application provides a user-friendly web interface accessible via smartphones, tablets, and computers, enabling professionals to securely store, organize, analyze, and share 3D data. Compatible with all major motion capture systems and various 3D motion data file formats, Moveshelf allows for seamless collaboration and data exchange among teams. The platform supports integration with open-source APIs in Python, Node.js, and popular development environments such as Unity, Unreal, and MATLAB. It offers a secure environment for movement scientists and healthcare professionals to generate interactive reports and datasets, facilitating effective communication and data analysis. Founded by experts in technology and motion tracking, Moveshelf aims to enhance the usability and accessibility of 3D human motion data, empowering professionals to achieve greater results in their work.

TargED Biopharmaceuticals is a biotechnology company focused on developing innovative biological drugs aimed at enhancing the treatment of thrombosis. The company utilizes small antibodies, known as VhH, to deliver enzymes directly to the sites of thrombus, facilitating targeted thrombolysis. This approach allows for effective treatment regardless of the blood clot's composition, thereby enabling healthcare professionals to accelerate patient care and improve outcomes for those affected by thrombosis.